SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-028484
Filing Date
2024-02-28
Accepted
2024-02-28 08:00:33
Documents
16
Period of Report
2024-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm246858d1_8k.htm   iXBRL 8-K 25165
2 EXHIBIT 99.1 tm246858d1_ex99-1.htm EX-99.1 97962
6 GRAPHIC tm246858d1_ex99-1img001.jpg GRAPHIC 15556
  Complete submission text file 0001104659-24-028484.txt   328541

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qure-20240228.xsd EX-101.SCH 3012
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qure-20240228_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qure-20240228_pre.xml EX-101.PRE 22357
17 EXTRACTED XBRL INSTANCE DOCUMENT tm246858d1_8k_htm.xml XML 3537
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36294 | Film No.: 24690235
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)